130 results on '"Renlund, Dale G."'
Search Results
2. Improving outcomes with long-term “destination” therapy using left ventricular assist devices
3. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions
4. Left ventricular assist device malfunction: a systematic approach to diagnosis
5. LONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS
6. Myocarditis
7. Impact of Mechanical Unloading on Microvasculature and Associated Central Remodeling Features of the Failing Human Heart
8. Abstract 2714: Heart Failure Device Therapy: Effect of Age and Gender on Patient Survival
9. Abstract 2702: Changes in Filling Pressures Rather than in Daily Weights Predict Heart Failure Events with Active Heart Failure Disease Management
10. Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure
11. Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic Mechanical Circulatory Support
12. Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution
13. Reply
14. Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients
15. Bridging the Resource Gap in Heart Failure Expertise and Management: The Underacknowledged Role of Nurse Specialists
16. Early Postoperative Use of Unfractionated Heparin or Enoxaparin is Associated with Increased Surgical Re-Exploration for Bleeding
17. Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?
18. Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy
19. 810-5 Use of either metformin or thiazolidinedione is associated with improved survival among patients with type 2 diabetes from a registry of 16,203 diabetic patients
20. Does secondary prevention with statins eliminate the risk of hyperhomocysteinemia?
21. Which features of the metabolic syndrome predict the presence of angiographic coronary artery disease?
22. Troponin-I and C-reactive protein have independent value for prediction of long-term risk after acute coronary syndromes: Utility of troponin-I is increased for women
23. Do statins provide clinical benefit in high-risk coronary artery disease patients with advanced left ventricular dysfunction?
24. Is atrial fibrillation an inflammatory disease reflected by elevated C-reactive protein?
25. Low socioeconomic status is more predictive of increased hazard in women than men after angiographic diagnosis of coronary artery disease
26. Angiotensin converting enzyme inhibition reduces elevated C-reactive protein in patients with angiographic coronary artery disease
27. Cytomegalovirus: Strength of antibody response and its relationship to risk of mortality among patients with angiographic coronary disease
28. Which features of the metabolic syndrome predict clinical outcomes (death/myocardial infarction) in patients with angiographic coronary artery disease?
29. Sensitivity of Rhythm Disturbance Detection by Community Hospital Telemetry
30. An institutional discharge medication program reduces future cardiovascular readmissions and mortality: an analysis of 43,841 patients with coronary artery disease
31. Inadequate prediction of death by the framingham risk model for patients with existing, angiographically- defined coronary artery disease
32. Increased incidence of surgical reexploration for postoperative bleeding due to early postoperative use of unfractionated heparin or enoxaparin
33. The intermountain risk model: predicting mortality by traditional and novel risk factors among patients with significant coronary disease
34. Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis
35. Reply
36. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
37. Left ventricular mass increases during cardiac allograft vascular rejection
38. Tricuspid valve dysfunction in the transplanted heart
39. Up-regulation of beta 2 -adrenergic receptors in previously transplanted, denervated nonfailing human hearts
40. Task force 5: Complications
41. Task force 6: Future developments
42. Mediastinitis in heart transplantation
43. Cardiac transplantation in a patient with a single ventricle and transposition of the great vessels
44. Low-dose enoximone in subjects awaiting cardiac transplantation
45. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation
46. Cardiac transplantation in situs inversus
47. Cardiac donor heart dysfunction: Evidence for catecholamine-mediated myocardial injury
48. Increased expression of β 2 -adrenergic receptors in surgically denervated, previously transplanted human ventricular myocardium
49. Sensitization to OKT3: Increased frequency with prolonged administration
50. Safety and efficacy of intraoperative vs postoperative administration of okt3 in orthotopic cardiac transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.